Skip to main content
. 2021 Oct 10;18:149. doi: 10.1186/s12984-021-00942-z

Table 4.

Secondary outcomes of impairment, balance, mood, cognition, and quality of life

Variable Exoskeleton n = 19 Mean (SD) Usual Care n = 17 Mean (SD) Group difference (95% CI) F-statistic p-valuea
FMA-lower
 Baseline 17.3 (6.6) 17.5 (7.0)
 Discharge 23.0 (5.9) 20.8 (7.1) 2.3 (− 0.4–5.1) F(1,33) = 2.95 0.09
 6-month 23.5 (6.0) 22.0 (5.2) 1.6 (− 1.4–4.5) F(1,33) = 1.19 0.28
BBS
 Baseline 15.3 (10.0) 19.2 (15.4)
 Discharge 36.6 (15.1) 37.8 (17.3) 1.4 (− 8.2–10.9) F(1,33) = 0.086 0.77
 6-month 40.3 (14.3) 43.0 (15.6) − 0.5 (− 9.0–7.9) F(1,33) = 0.017 0.90
PHQ-9
 Baseline 7.2 (4.2) 7.7 (6.4)
 Discharge 4.1 (3.3) 6.1 (7.4) − 1.6 (− 4.5–1.3) F(1,33) = 1.289 0.26
 6-month 5.1 (4.0) 6.8 (6.5) − 1.4 (− 3.6–0.8) F(1,33) = 1.599 0.22
MoCAb
 Baseline 22.4 (4.3) 23.5 (5.0)
 Discharge 24.9 (5.2) 24.6 (5.2) 1.5 (− 0.2–3.1) F(1,29) = 3.456 0.07
 6-month 24.6 (4.8) 25.1 (4.9) 0.4 (− 1.6–2.4) F(1,29) = 0.185 0.67
SF-36-physicalc
 Baseline 30.2 (8.9) 28.2 (6.5)
 Discharge 31.8 (9.7) 28.7 (8.8) 2.3 (− 3.9–8.5) F(1,31) = 0.591 0.45
 6-month 33.5 (9.9) 30.8 (10.5) 1.9 (− 5.1–8.8) F(1,31) = 0.298 0.59
SF-36-mentalc
 Baseline 51.0 (10.4) 49.4 (12.4)
 Discharge 52.5 (12.6) 52.6 (14.7) − 1.1 (− 9.3–7.0) F(1,31) = 0.079 0.78
 6-month 50.1 (12.5) 52.4 (13.2) − 3.2 (− 11.0–4.5) F(1,31) = 0.723 0.40

BBS Berg Balance Scale, FMA-LE lower extremity component of Fugl-Meyer Assessment, MoCA Montreal cognitive assessment, PHQ-9 Patient Health Questionnaire, SD standard deviation, SF-36-Mental mental component of 36-item short form survey, SF-36-Physical physical component of 36-item short form survey

aAll outcomes analyzed using ANCOVA, using baseline score as covariate

bExoskeleton n = 17; Usual Care n = 15

cExoskeleton n = 18; Usual Care n = 16